Smith Group Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-24,510
| Closed | -$3.83M | – | 348 |
|
|
2020
Q4 | $3.83M | Sell |
24,510
-11,900
| -33% | -$1.86M | 0.22% | 72 |
|
|
2020
Q3 | $4.17M | Sell |
36,410
-60
| -0.2% | -$6.87K | 0.22% | 83 |
|
|
2020
Q2 | $4.09M | Sell |
36,470
-16,920
| -32% | -$1.9M | 0.23% | 83 |
|
|
2020
Q1 | $4.79M | Sell |
53,390
-2,270
| -4% | -$204K | 0.26% | 82 |
|
|
2019
Q4 | $6.02M | Buy |
+55,660
| New | +$6.02M | 0.25% | 84 |
|
|
2015
Q1 | – | Sell |
-87,877
| Closed | -$16.3M | – | 463 |
|
|
2014
Q4 | $16.3M | Buy |
87,877
+10
| +0% | +$1.85K | 0.57% | 67 |
|
|
2014
Q3 | $14.6M | Buy |
87,867
+567
| +0.6% | +$94K | 0.54% | 71 |
|
|
2014
Q2 | $13.6M | Buy |
+87,300
| New | +$13.6M | 0.5% | 73 |
|